Pharmafile Logo

Etymax Ltd.

Etymax is a leading translation provider and language consultancy. We supply global language solutions to international companies across industry sectors, covering commercial, professional, technical and creative translations. Based in central London, we are at the hub of the global business world and are therefore ideally placed for the centralised coordination of multilingual materials. Our applied expertise in core industry terminologies helps businesses maximise their success across global markets through high quality translation, copy adaptation and all language related services.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Atlas Translations Ltd

With Atlas Translations Ltd you get a service that is both personal and professional. This means that your message will be understood in the language and context you need it…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Company Details

6 Bickels Yard, 151-153 Bermondsey Street, London, SE1 3HA, United Kingdom
+44 (0)20 7089 9098

 Latest Content from PMHub 

Extraordinary lives: advancing change in rare diseases (Part 1)

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on...

How do doctors spend their time online?

In our recent research piece, Doctor networks: The rules of engagement for pharma, some overarching principles for online engagement between the pharmaceutical industry and doctors were defined.

The Seven Year Switch

Press Releases | March 14, 2022 | 11 London

7 years ago this month, no-one had heard of Covid 19 – let alone PCR tests. The UK was in the EU, Donald Trump was only really known for being...

Increasing patient randomisation rate by 200% for a Top 5 global pharma

Phase IIa Moderate to Severe Hidradenitis Suppurativa Case Study

Creative Director, Europe appointment at Nucleus Global

Press Releases | March 10, 2022 | Nucleus Global

We hear from Trevor Telo, Nucleus Global’s new Creative Director, Europe, about his experience and ambitions for the role

Top 10 Tips to Increase Engagement During Virtual Events

If you are a member of the Medical Affairs Professional Society (MAPS), you might have caught our popular webinar on how COVID-19 has impacted (and will continue to impact) live...

Consumer-driven Healthcare in the Digital Age

Dr. Gil Blander, Co-founder & Chief Scientific Officer at InsideTracker, explores consumer-driven healthcare, the use of big data and AI for creating personalized health protocols, the trillion-dollar “longevity economy,” and...

My Journey into MedComms #LucidLife

I began as a medical writer after almost a decade working in medical publishing as a production editor. Whilst working in publishing, I was exposed to lots of different writing...

International Women’s Day 2022 #BreakTheBias

Today is International Women’s Day. This day is about gender equality, which, to be achieved, must involve the calling out of gender bias, discrimination and stereotyping.Individually, we're all responsible for...